| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/22/2007 | WO2005112881A8 The dispersible montmorillonite tablet and its preparation technology |
| 02/22/2007 | WO2005089148A3 Delivery of genes encoding short hairpin rna using receptor-specific nanocontainers |
| 02/22/2007 | WO2005070466A3 Liposome composition for delivery of therapeutic agents |
| 02/22/2007 | WO2005046646A3 Blister pack and solid dosage form comprising desmopressin |
| 02/22/2007 | WO2005011616A3 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease |
| 02/22/2007 | WO2004098491A3 METHOD OF PREVENTING INFECTIONS FROM BIOTERRORISM AGENTS WITH IMMUNOSTIMULATORY CpG OLIGONUCLEOTIDES |
| 02/22/2007 | WO2004063876A3 Programmed pulsed infusion methods and devices |
| 02/22/2007 | US20070043335 Miniature pump for drug delivery |
| 02/22/2007 | US20070043332 Intravaginal drug delivery devices |
| 02/22/2007 | US20070043327 Drug delivery device comprising a mesh sleeve |
| 02/22/2007 | US20070043200 Use of an amorphous polyester as a polymer base for masticatory substances |
| 02/22/2007 | US20070043163 Method for emulsion polymerisation of olefins |
| 02/22/2007 | US20070043119 Pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
| 02/22/2007 | US20070043102 Oral suspension of tegaserod |
| 02/22/2007 | US20070043004 High drug load mesalazine sachet |
| 02/22/2007 | US20070042994 Pharmaceutical compositions comprising peranhydrocyclodextrin |
| 02/22/2007 | US20070042990 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 02/22/2007 | US20070042979 Oligonucleic acid-bearing composite and pharmaceutical composition containing the composite |
| 02/22/2007 | US20070042973 Treatment of pain and fever |
| 02/22/2007 | US20070042943 Cyclosporin active, fatty acid triglyceride, glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, preferably, and a tenside having an HLB of at least 10; immunosuppressant, anti inflammatory, anti parasitic |
| 02/22/2007 | US20070042942 Glycopeptide carboxy-saccharide derivatives |
| 02/22/2007 | US20070042507 Composite nanoparticles |
| 02/22/2007 | US20070042338 Enriched with oxygen and comprises base nutritive medium and liposomes comprising cholesterol; biopsies; freezing; drug screening |
| 02/22/2007 | US20070042062 Novel anti-diabetic herbal formulation |
| 02/22/2007 | US20070042051 Remedy ointment for piles and their manufacturing method |
| 02/22/2007 | US20070042050 Nucleic acid vaccine compositions having a mammalian CD80/CD86 gene promoter driving antigen expression |
| 02/22/2007 | US20070042049 Nanoparticulate benidipine compositions |
| 02/22/2007 | US20070042048 Devices, Compositions and Methods for the Pulmonary Delivery of Aerosolized Medicaments |
| 02/22/2007 | US20070042046 Methods for the treatment of cancer |
| 02/22/2007 | US20070042045 Multilayer dosage form comprising a matrix that influences release of a modulatory substance |
| 02/22/2007 | US20070042044 Matrix compositions for controlled delivery of drug substances |
| 02/22/2007 | US20070042043 Pellet formulations of acid-labile benzimidazonle compounds |
| 02/22/2007 | US20070042042 Metformin Tablet with Sustained Release and Method for Preparing the Same |
| 02/22/2007 | US20070042041 Drug-surfactant complexes for sustained release |
| 02/22/2007 | US20070042040 Methods and compositions using gonadotropin hormone releasing hormone |
| 02/22/2007 | US20070042039 Mixing calcium carbonate powder having a median particle diameter between about 0.1 and about 20 mu m in a high shear mixer; drying in a fluidized bed oven, thereby resulting in a calcium carbonate granulation having a tap density between about 0.9 g/cm3 and about 2.0 g/cm3; provide smaller tablet sizes |
| 02/22/2007 | US20070042038 Progestin co-micronized with a surfactant, pharmaceutical composition comprising same, methods for making same and uses thereof |
| 02/22/2007 | US20070042037 Pharmaceutical composition containing levodopa and carbidopa |
| 02/22/2007 | US20070042036 Fat-soluble drug composition |
| 02/22/2007 | US20070042035 applying capsule anti-sticking agent, enzymatically decomposed lecithin, on surface; improved water activity, disintegration property |
| 02/22/2007 | US20070042034 High drug load formulations and dosage forms |
| 02/22/2007 | US20070042033 Pantoprazole multiparticulate formulations |
| 02/22/2007 | US20070042032 Self forming, thermodynamically stable liposomes and their applications |
| 02/22/2007 | US20070042031 Systems and methods for manufacturing liposomes |
| 02/22/2007 | US20070042030 Preparation for the application of agents in mini-droplets |
| 02/22/2007 | US20070042029 Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R) |
| 02/22/2007 | US20070042028 Plaster causing reduced skin irritation |
| 02/22/2007 | US20070042023 Dissolvable film |
| 02/22/2007 | US20070042009 Topical composition for delivery of salicylates |
| 02/22/2007 | US20070042008 Compositions containing phosphatidylcholine and essential fatty acids |
| 02/22/2007 | US20070042007 Topical composition for delivery of salicylate esters |
| 02/22/2007 | US20070042006 Stable carprofen composition |
| 02/22/2007 | US20070042005 Pharmaceutical composition comprising fungal cell or fragment thereof |
| 02/22/2007 | US20070041944 Treating tumors by ENH dislocation of ID proteins |
| 02/22/2007 | US20070041939 Modified cytokines for use in cancer therapy |
| 02/22/2007 | US20070041938 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor |
| 02/22/2007 | US20070041916 Preparation containing diol |
| 02/22/2007 | US20070041912 Trospium containing compositions |
| 02/22/2007 | US20070041908 Injectable composite for the magnetocytolysis of bone metastatic cells |
| 02/22/2007 | US20070041906 Bone substitute composition |
| 02/22/2007 | US20070041866 Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant |
| 02/22/2007 | DE102005039579A1 Composition, useful e.g. for prophylaxis and treatment of cancer disease, comprises a nano particle, a therapeutic substance, a carrier, auxiliary material and/or solvent |
| 02/22/2007 | DE102005033943A1 Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für ein Neuroleptikum Non-ausspuckbarer, oral, fast-disintegrating film for a neuroleptic |
| 02/22/2007 | DE102005033942A1 Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für Antiemetikum oder Antimigränemittel Non-ausspuckbarer, oral, fast-disintegrating film for anti-emetic or anti-migraine agents |
| 02/22/2007 | CA2770408A1 Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith |
| 02/22/2007 | CA2619745A1 Tablet with multiple drug-containing sections |
| 02/22/2007 | CA2619744A1 Formulation having accurate dose-dividing function |
| 02/22/2007 | CA2619214A1 Factor xa inhibitor inclusion complex with cyclodextrin |
| 02/22/2007 | CA2618993A1 Topical delivery with a carrier fluid |
| 02/22/2007 | CA2618871A1 Ophthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization |
| 02/22/2007 | CA2618702A1 Sustained release antihistamine and decongestant composition |
| 02/22/2007 | CA2618468A1 Process for the preparation of a stable dispersion of sub-micron particles in an aqueous medium |
| 02/22/2007 | CA2618439A1 Technique for stabilization of yw753 reparation |
| 02/22/2007 | CA2618349A1 Intravesical drug delivery device and method |
| 02/22/2007 | CA2618076A1 Drug-surfactant complexes for sustained release |
| 02/22/2007 | CA2618018A1 A concentrated liquid formulation comprising a s1p receptor agonist |
| 02/22/2007 | CA2617963A1 Oil-in-water-type emulsion for topical application in dermatology |
| 02/22/2007 | CA2617367A1 Solid dosage forms of valsartan and amlodipine and method of making the same |
| 02/22/2007 | CA2617106A1 Estrogen compositions and therapeutic methods of use thereof |
| 02/22/2007 | CA2615121A1 Method of treating parturient placental mammals in order to reduce maternal and/or uterine exhaustion |
| 02/21/2007 | EP1754491A1 Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist |
| 02/21/2007 | EP1754488A1 Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases |
| 02/21/2007 | EP1754482A1 Use of an ascomycin for the treatment of blepharitis |
| 02/21/2007 | EP1754479A1 Capsule stable against mastication |
| 02/21/2007 | EP1754472A2 Compositions for treatment of disorders associated with chlamydia |
| 02/21/2007 | EP1754471A1 Use of a swelling intermediate layer for controlling the release profile of a solid pharmaceutical form for peroral administration and pharmaceutical form containing said layer |
| 02/21/2007 | EP1754470A1 Fat-soluble drug composition |
| 02/21/2007 | EP1754469A1 Injectable suspensions having improved injectability properties |
| 02/21/2007 | EP1753852A1 Compositions with health and nutrition promoting characteristics, containing interestified lipids and phytosterol, and related methods |
| 02/21/2007 | EP1753810A1 A dried and agglomerated hyaluronic acid product |
| 02/21/2007 | EP1753803A2 Polypeptides with the capacity to entrap drugs and release them in a controlled way |
| 02/21/2007 | EP1753787A1 Method of covalently linking hyaluronan and chitosan |
| 02/21/2007 | EP1753759A2 Novel co-precipitate of amorphous rosiglitazone |
| 02/21/2007 | EP1753615A2 Films comprising a liquid-absorbant inner layer, an antimicrobial material and an impermeable outer layer |
| 02/21/2007 | EP1753529A1 Compositions containing a hollow glucan particle or a cell wall particle encapsulating a terpene component, methods of making and using them |
| 02/21/2007 | EP1753499A2 Packaging for therapeutic agent |
| 02/21/2007 | EP1753461A1 Stabilized compositions comprising a therapeutically active agent, citric acid or a conjugated base and chlorine dioxide |
| 02/21/2007 | EP1753445A2 Treatment of ocular diseases and disorders using lantibiotic compositions |
| 02/21/2007 | EP1753440A1 Oral form of administration containing probiotic bacteria |
| 02/21/2007 | EP1753438A2 New hydroxapatite calcium phosphates, their method of preparation and their applications |